Atlas Trials

Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome.

Clinical trial NCT03723798 · COMPLETED

Trial details

NCT number
NCT03723798
Sponsor
Samjin Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Dry Eye Syndrome
Start date
2017-11-08
Primary completion
2018-10-01
Enrollment
172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.